Carissa Karg

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

Nyaradzo Mgodi, Simbarashe Takuva, Srilatha Edupuganti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 45 citations · Full text

Public Health, Community Health, Immunology +17

Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody

Srilatha Edupuganti, Nyaradzo Mgodi, Shelly Karuna et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 26 citations · Full text

Public Health, Immunology, Pharmacotherapy +17

Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region

Shelly Karuna, Jorge A. Gallardo-Cartagena, Deborah Theodore et al. · Journal of Global Health · 2023 · 19 citations · Full text

Veterinary Medicine, Health Sciences, Infectious Diseases +14

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

Stephen R. Walsh, Cynthia L. Gay, Shelly Karuna et al. · PLoS Medicine · 2024 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials

Simbarashe Takuva, Shelly Karuna, Michal Juraska et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2021 · 11 citations · Full text

Public Health, Immunology, Pharmacotherapy +12